Grifois, S.A. (GRFS)
- Headquarters
- United States
- Employees
- 25,247
- Market Cap
- $5.6B
About Grifois, S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
SentiSense also tracks daily options readings for Grifois, S.A.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Grifois, S.A. stock analysis, sentiment tracking, and market intelligence on SentiSense.